The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene
Abstract
The 16p13.3 breakpoints of two de novo translocations of chromosome 16, t(1;16) and t(14;16), were shown by initial mapping studies to have physically adjacent breakpoints. The translocations were ascertained in patients with abnormal phenotypes characterized by predominant epilepsy in one patient and mental retardation in the other. Distamycin/DAPI banding showed that the chromosome 1 breakpoint of the t(1;16) was in the pericentric heterochromatin therefore restricting potential gene disruption to the 16p13.3 breakpoint. The breakpoints of the two translocations were localized to a region of 3.5 and 115 kb respectively and were approximately 900 kb apart. The mapping was confirmed by fluorescence in situ hybridization (FISH) of clones that spanned the breakpoints to metaphase spreads derived from the patients. The mapping data showed both translocations disrupted the ataxin-2-binding protein 1 ( A2BP1) gene that encompasses a large genomic region of 1.7 Mb. A2BP1 encodes a protein that is known to interact with the spinocerebellar ataxia type 2 ( SCA2) protein. It is proposed that disruption of the A2BP1 gene is a cause of the abnormal phenotype of the two patients. Ninety-six patients with sporadic epilepsy and 96 female patients with mental retardation were screened by SSCP for potential mutations of A2BP1. No mutations were found, suggesting that disruption of the A2BP1 gene is not a common cause of sporadic epilepsy or mental retardation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Combined with neuro-developmental defects observed in cell cultures (Kim et al., 2013), animal models (Gehman et al., 2012; Gehman et al., 2011; Kim et al., 2013), and human patients (Bhalla et al., 2004) where Rbfox proteins are disrupted, this presents a compelling case for Rbfox proteins playing critical roles in driving the global dynamic change of the developmentalsplicing-regulatory program.”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Bhalla et al., 2004
In the citing paper
“Human mutations in RBFOX1 have been identified in patients with epilepsy126–128”
From The neurogenetics of alternative splicing (2016) · cites this paper as [126]
Citations
Cites
Warburton, D. (1991) · Europe PMC (PubMed Central) · Cited by 673
A novel protein with RNA-binding motifs interacts with ataxin-2
Shibata, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1303 · Cited by 221
Callen, D. F., Baker, E., Hj, E., Je, C., Ja, B., & Sutherland, G. R. (1990) · PubMed · Cited by 87
Self-citationIdentification and expression of a mouse ortholog of A2BP1
Kiehl, T., Shibata, H., Vo, T., Huynh, D., & Pulst, S. (2001) · Mammalian Genome · doi:10.1007/s00335-001-2056-4 · Cited by 55
Callen, D. F., Lane, S. A., Kozman, H. M., Kremmidiotis, G., Whitmore, S. A., Lowenstein, M. G., Doggett, N. A., Kenmochi, N., Page, D. C., Maglott, D. R., et al. (1995) · Genomics · doi:10.1006/geno.1995.9005 · Cited by 45
Self-citationCallen, D. F., Eyre, H. J., McDonnell, S., Schuffenhauer, S., & Bhalla, K. N. (2002) · Chromosoma · doi:10.1007/s00412-002-0203-7 · Cited by 9
Self-citation
Cited by
Sorted by citations
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Cooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,198
Functional consequences of developmentally regulated alternative splicing
Kalsotra, A., & Cooper, T. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3052 · Cited by 729
Ropers, H., & Hamel, B. C. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1501 · Cited by 523
Metadata
- Authors
- Bhalla, K., Phillips, H. A., Crawford, J., McKenzie, O. L. D., Mulley, J. C., Eyre, H., Gardner, A. E., Kremmidiotis, G., & Callen, D. F.
- Affiliations
- Women's and Children's Hospital (AU)
- South Australia Pathology (AU)
- Corresponding author
- Callen, David F.
- Venue
- Journal of Human Genetics
- Published
- 2004-05-18
- Volume
- 49
- Issue
- 6
- Pages
- 308-311
- ISSN
- 1434-5161 (ISSN-L)
- 1435-232X
- OpenAlex
- W2086863891
- Cited by
- 146
- References
- 6
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 3 · 2020: 10 · 2019: 6 · 2018: 10 · 2017: 8 · 2016: 11 · 2015: 6 · 2014: 12 · 2013: 12 · 2012: 6
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- gene disruption, epilepsy, intellectual disability, spinocerebellar ataxia type 2, pericentromeric heterochromatin, breakpoint mapping, fluorescence in situ hybridization
- MeSH terms
- Ataxins, RNA Splicing Factors, Adolescent, Child, Preschool, Chromosome Mapping, Chromosomes, Human, Pair 16, Epilepsy, Exons, Female, Humans, Introns, Male, Intellectual Disability, Models, Genetic, Mutation, Nerve Tissue Proteins, Phenotype, Proteins, Translocation, Genetic, RNA-Binding Proteins, In Situ Hybridization, Fluorescence, Polymorphism, Single-Stranded Conformational, Physical Chromosome Mapping
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
